After decades of failure in Alzheimer’s disease research, scientists are buoyed by new findings that could mark a turning point in the field, offering hope that treatment may someday slow the grim deterioration of the brain.
The data, published in the prestigious New England Journal of Medicine and presented to applause at a sold-out conference in San Francisco, California, United States, last week, showed a substantial reduction in damaging brain plaques and some modest slowing of cognitive decline in patients with early disease.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
